Yingxu Peng

Title: Innovations by Yingxu Peng in Tamper Prone Therapeutic Agents

Introduction

Yingxu Peng is a notable inventor based in Paoli, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of dosage forms that enhance the safety and efficacy of therapeutic agents. With a total of 4 patents to his name, his work focuses on addressing the challenges posed by tampering in medication delivery.

Latest Patents

One of Yingxu Peng's latest patents is centered around dosage forms for tamper prone therapeutic agents. This innovative dosage form is designed to reduce or retard the burst release of a drug contained within a tampered dosage form. The presence of a Tamper Prone Therapeutic Agent (TPTA) trap in or on the dosage form plays a crucial role in this mechanism. If the dosage form remains untampered, the TPTA trap does not significantly interfere with the drug's release rate. However, in cases where the dosage form has been physically tampered with, the TPTA trap effectively reduces or retards the burst release of the drug, enhancing patient safety.

Career Highlights

Yingxu Peng is currently associated with Atlantic Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical sector. His work is characterized by a commitment to improving drug delivery systems and ensuring the safety of therapeutic agents.

Collaborations

Yingxu has collaborated with notable colleagues such as Anthony Edward Soscia and Yichun Sun, contributing to a dynamic research environment that fosters innovation.

Conclusion

Yingxu Peng's contributions to the field of pharmaceuticals, particularly through his patents on tamper prone therapeutic agents, highlight his dedication to enhancing medication safety. His work at Atlantic Pharmaceuticals, Inc. continues to pave the way for advancements in drug delivery systems.